semaglutide nash results 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial Metabolic dysfunction-associated steatotic liver disease

Lithium, in particular, remains under-prescribed despite its strong efficacy in BD, limiting its overall public health impact

For patients whose pain can be managed with acetaminophen, it remains the preferred first-line analgesic alongside levothyroxine therapy, consistent with ACR 2019 osteoarthritis management guidelines and general primary care practice

Naturally, the level of concern with this drug combination is heightened for certain individuals

Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)

The discovery of a specific biomarker with a high sensitivity for nonsurgical endometriosis detection would promise an earlier diagnosis and prevention of deleterious sequelae